on 20 May 2019
Last Applicant/ Owned by
CH-4002 Basel
CH
Serial Number
79074135 filed on 20th May 2009
Registration Number
3845464 registered on 07th Sep 2010
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourniary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for Read More
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourniary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; antifungal preparations; anti-infectives, antiviral; antibiotics; vaccines, diagnostic preparations for medical use
No 79074135
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
23rd Dec 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
23rd Dec 2019 | DEATH OF INTERNATIONAL REGISTRATION |
03rd Nov 2017 | NOTIFICATION PROCESSED BY IB |
28th Oct 2016 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
28th Oct 2016 | DEATH OF INTERNATIONAL REGISTRATION |
13th Apr 2013 | NEW REPRESENTATIVE AT IB RECEIVED |
23rd Feb 2013 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
01st Jan 2011 | FINAL DECISION TRANSACTION PROCESSED BY IB |
10th Dec 2010 | FINAL DISPOSITION PROCESSED |
10th Dec 2010 | FINAL DISPOSITION NOTICE SENT TO IB |